9th Annual EU Medical Device & Diagnostic Reimbursement & Market Access Conference

March 24-25, 2020 | Frankfurt, Germany

9th Annual EU Medical Device & Diagnostic Reimbursement & Market Access Conference
March 24-25, 2020 | Frankfurt, Germany

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

The 9th edition of the Q1 European Device & Diagnostic Reimbursement & Market Access Conference will once more shed light on strategies to overcome ongoing challenges through various session formats including practical workshops, discussions and presentations. Participants are ensured to collect a maximized number of take-home messages relevant to pressing challenges such as demonstrating scientific and economic value in a targeted and impactful manner, as well as developing services to bundle with medical technology to ultimately engage in integrated care. The speaker faculty, ranging from thought industry leaders and academia to HTA reviewers and Payers will once more unveil practical advice on the best approach to distinct EU markets, making this program the annual must-attend event for the industry.

Topics to be Addressed:

  • Updates into member state HTA evidence expectations & requirements
  • Clarification of the MDR impact on clinical & follow-on impact on reimbursement
  • Insight into the HTx Project & benefits for the medtech industry
  • Reimbursement opportunities for medical device & healthcare apps
  • Leveraging compliance with new EU regulatory frameworks to positively influence purchasers
  • Efficiently collaborating with clinical teams to ensure appropriate evidence generation

Topics to be Addressed:

  • Updates into member state HTA evidence expectations & requirements
  • Clarification of the MDR impact on clinical & follow-on impact on reimbursement
  • Insight into the HTx Project & benefits for the medtech industry
  • Reimbursement opportunities for medical device & healthcare apps
  • Leveraging compliance with new EU regulatory frameworks to positively influence purchasers
  • Efficiently collaborating with clinical teams to ensure appropriate evidence generation

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from medical device and diagnostic companies

Distinguished Presenters

Speaker recruitment in progress

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This